Everspin Technologies, Inc. (LON:0IJ3)
10.56
-0.12 (-1.12%)
At close: Oct 27, 2025
Everspin Technologies Revenue
Everspin Technologies had revenue of $13.20M USD in the quarter ending June 30, 2025, with 24.12% growth. This brings the company's revenue in the last twelve months to $51.68M, down -11.27% year-over-year. In the year 2024, Everspin Technologies had annual revenue of $50.40M, down -20.96%.
Revenue (ttm)
$51.68M
Revenue Growth
-11.27%
P/S Ratio
4.92
Revenue / Employee
$593.97K
Employees
87
Market Cap
185.43M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.40M | -13.36M | -20.96% |
| Dec 31, 2023 | 63.77M | 3.78M | 6.30% |
| Dec 31, 2022 | 59.99M | 4.84M | 8.77% |
| Dec 31, 2021 | 55.15M | 13.12M | 31.20% |
| Dec 31, 2020 | 42.03M | 4.53M | 12.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |